注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Soligenix Inc是一家後期生物製藥公司。該公司專注於開發治療罕見疾病的產品。該公司通過兩個部門運營:專業生物治療和公共衛生解決方案。專業生物治療部門包括開發HyBryte(SGX301或合成金絲桃素)一種用於治療皮膚T細胞淋巴瘤(CTCL)的光動力療法。公共衛生解決方案部門包括RiVax,以防止暴露於蓖麻毒素疫苗候選疫苗和SGX943治療候選抗生素耐藥性和傳染病。該公司的開發項目包括天然防禦調節劑(IDR)技術、用於治療炎症性疾病、頭頸癌口腔粘膜炎的杜斯奎特(SGX942)以及用於預防/治療胃腸道疾病(包括兒童克羅恩病(SGX203))的口服倍氯米松17,21-二丙酸酯(BDP)。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Mark Schubert | - | - | Member of Oral Mucositis Medical Advisory Board |
James Markowitz | - | - | Member of Pediatric Crohn's Disease Medical Advisory Board |
Gary Wood | - | - | Member of Cutaneous T-Cell Lymphoma Medical Advisory Board |
Christopher J. Schaber | 58 | 2006 | Chairman of the Board of Directors, CEO & President |
W. Joost Wiersinga | - | - | Member of Melioidosis Scientific Advisory Board |
Gregory Anthony Lapointe | 65 | 2009 | Independent Director |
Alain H. Rook | - | - | Member of Cutaneous T-Cell Lymphoma Medical Advisory Board |
Jeffrey Hyams | - | - | Member of Pediatric Crohn's Disease Medical Advisory Board |
Joel Rosh | - | - | Member of Pediatric Crohn's Disease Medical Advisory Board |
Bart Currie | - | - | Member of Melioidosis Scientific Advisory Board |
Yusuf Yazici | - | 2024 | Member of Behcet's Disease Medical Advisory Board |
Direk Limmathurotsakul | - | - | Member of Melioidosis Scientific Advisory Board |
Andrew Sulich | - | 2024 | Member of Behcet's Disease Medical Advisory Board |
Robert J. Rubin | 78 | 2009 | Independent Director |
Dorothy Mary Kate Keefe | - | - | Member of Oral Mucositis Medical Advisory Board |
Jerome Bernard Zeldis | 74 | 2011 | Independent Director |
Youn Kim | - | - | Member of Cutaneous T-Cell Lymphoma Medical Advisory Board |
Madeleine Duvic | - | - | Member of Cutaneous T-Cell Lymphoma Medical Advisory Board |
David AB Dance | - | - | Member of Melioidosis Scientific Advisory Board |
Diane L. Parks | 72 | 2019 | Independent Director |
Johannes Nowatzky | - | 2024 | Member of Behcet's Disease Medical Advisory Board |
Gülen Hatemi | - | 2024 | Member of Behcet's Disease Medical Advisory Board |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核